IGC Pharma, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2021
Total Assets: $35.9M
Liabilities Breakdown FY2021
Total Liabilities: $3.1M
Asset Breakdown
Total Assets: $35.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $14.5M | 40.6% |
| Accounts Receivable | $175.0K | 0.5% |
| Inventory | $5.5M | 15.3% |
| Property, Plant & Equipment | $10.8M | 30.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $407.0K | 1.1% |
| Other Assets | $4.4M | 12.3% |
Liabilities Breakdown
Total Liabilities: $3.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $476.0K | 15.5% |
| Long-Term Debt | $276.0K | 9.0% |
| Other Liabilities | $2.3M | 75.5% |